Malik A, Ali F, Malik M, Qureshi S
Gastroenterology Res. 2024; 17(3):133-145.
PMID: 38993548
PMC: 11236340.
DOI: 10.14740/gr1715.
Moinova H, Verma S, Dumot J, Faulx A, Iyer P, Canto M
Am J Gastroenterol. 2024; 119(11):2206-2214.
PMID: 38686933
PMC: 11534537.
DOI: 10.14309/ajg.0000000000002850.
Lu C, Liu L, Yin M, Lin J, Zhu S, Gao J
Front Med (Lausanne). 2024; 11:1266278.
PMID: 38633305
PMC: 11021582.
DOI: 10.3389/fmed.2024.1266278.
Cheng Y, Wang G, Zhou X, Lin M, Zhang X, Huang Q
World J Gastrointest Oncol. 2024; 16(2):563-570.
PMID: 38425401
PMC: 10900165.
DOI: 10.4251/wjgo.v16.i2.563.
Arshad H, Farooq U, Cheema A, Arshad A, Masood M, Vega K
World J Gastrointest Endosc. 2024; 15(12):715-724.
PMID: 38187915
PMC: 10768036.
DOI: 10.4253/wjge.v15.i12.715.
Endoscope Capsules: The Present Situation and Future Outlooks.
Gounella R, Granado T, Hideo Ando Junior O, Luporini D, Gazziro M, Carmo J
Bioengineering (Basel). 2023; 10(12).
PMID: 38135938
PMC: 10741108.
DOI: 10.3390/bioengineering10121347.
Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.
Ajay P, Rajamanickam R, Rhee K, NeMoyer R, Goyal S, Switchenko J
Surg Endosc. 2023; 38(1):136-147.
PMID: 37935921
PMC: 10843560.
DOI: 10.1007/s00464-023-10515-x.
Identification of sentinel lymph nodes in esophageal cancer patients using contrast-enhanced EUS with peritumoral injections.
Liu J, Machado P, Eisenbrey J, Gummadi S, Forsberg F, Wessner C
Endosc Ultrasound. 2023; 12(4):362-368.
PMID: 37795347
PMC: 10547247.
DOI: 10.1097/eus.0000000000000001.
Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica.
Yang Y, Wang X, Duan C, Wang Z, Sheng H, Xu X
Sci Rep. 2023; 13(1):15115.
PMID: 37704736
PMC: 10500003.
DOI: 10.1038/s41598-023-42456-9.
Proximal gastrectomy and double-tract reconstruction vs total gastrectomy in gastric and gastro-esophageal junction cancer patients - a systematic review and meta-analysis protocol (PROSPERO registration number: CRD42021291500).
Hipp J, Kuvendjiska J, Martini V, Hillebrecht H, Fichtner-Feigl S, Diener M
Syst Rev. 2023; 12(1):150.
PMID: 37644614
PMC: 10463580.
DOI: 10.1186/s13643-023-02304-3.
The uneven decline of gastric cancer in the USA: epidemiology of a health disparity.
Rabkin C
Lancet Reg Health Am. 2023; 24:100551.
PMID: 37600162
PMC: 10435833.
DOI: 10.1016/j.lana.2023.100551.
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.
Mazidimoradi A, Amiri S, Khani Y, Allahqoli L, Salehiniya H
Thorac Cancer. 2023; 14(24):2361-2407.
PMID: 37455657
PMC: 10447175.
DOI: 10.1111/1759-7714.15026.
Downregulation of SODD mediates carnosol-induced reduction in cell proliferation in esophageal adenocarcinoma cells.
Li A, Cao W
Sci Rep. 2023; 13(1):10580.
PMID: 37386230
PMC: 10310760.
DOI: 10.1038/s41598-023-37796-5.
Can Clinical Stage in the 8 Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?.
Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H
In Vivo. 2023; 37(4):1790-1796.
PMID: 37369497
PMC: 10347905.
DOI: 10.21873/invivo.13268.
The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes.
Blaine-Sauer S, Samuels T, Yan K, Johnston N
Int J Mol Sci. 2023; 24(7).
PMID: 37047737
PMC: 10095080.
DOI: 10.3390/ijms24076765.
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Gronnier C, Mariette C, Lepage C, Monterymard C, Jary M, Ferru A
Cancers (Basel). 2023; 15(7).
PMID: 37046849
PMC: 10093434.
DOI: 10.3390/cancers15072188.
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG.
Milone M, DAmore A, Alfieri S, Ambrosio M, Andreuccetti J, Ansaloni L
Updates Surg. 2022; 75(4):931-940.
PMID: 36571661
DOI: 10.1007/s13304-022-01438-8.
Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma.
Liang R, Bi X, Fan D, Du Q, Wang R, Zhao B
Front Oncol. 2022; 12:913960.
PMID: 36518305
PMC: 9743047.
DOI: 10.3389/fonc.2022.913960.
Transthoracic, thoracoabdominal, and transabdominal surgical approaches for gastric cardia adenocarcinomas: a survival evaluation based on a cohort of 7103 patients.
Chen Y, Zhao X, Xu R, Song X, Yang M, Zhou F
World J Surg Oncol. 2022; 20(1):217.
PMID: 35764996
PMC: 9238161.
DOI: 10.1186/s12957-022-02680-5.
A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway.
Fang J, Wang Y, Wang Z, Xie T, Yan F, Wang L
Transl Cancer Res. 2022; 9(7):4131-4140.
PMID: 35117782
PMC: 8798537.
DOI: 10.21037/tcr-19-975.